nobiletin has been researched along with Atherogenesis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YS; He, PP; Hu, LZ; Liu, J; Ouyang, XP; Shen, QQ; Su, H; Tang, CK; Wang, Y; Wen, M; Yang, JX; Zheng, XL; Zou, JQ | 1 |
| Fu, SH; Ho, CT; Li, S; Lo, YH; Pan, MH; Weng, CY; Wu, MJ; Yen, JH | 1 |
| Allister, EM; Assini, JM; Charbonneau, A; Edwards, JY; Huff, MW; Koppes, JB; Lee, JK; Marette, A; Mulvihill, EE; Sawyez, CG; St-Pierre, P; Sutherland, BG; Telford, DE | 1 |
| Assini, JM; Huff, MW; Mulvihill, EE | 1 |
1 review(s) available for nobiletin and Atherogenesis
| Article | Year |
|---|---|
Citrus flavonoids and lipid metabolism.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Citrus; Dyslipidemias; Flavanones; Flavones; Hesperidin; Humans; Hypolipidemic Agents; Inflammation; Lipid Metabolism; Oxidation-Reduction; Phytotherapy | 2013 |
3 other study(ies) available for nobiletin and Atherogenesis
| Article | Year |
|---|---|
Nobiletin reduces LPL-mediated lipid accumulation and pro-inflammatory cytokine secretion through upregulation of miR-590 expression.
Topics: Atherosclerosis; Cardiotonic Agents; Cytokines; Down-Regulation; Drug Development; Flavones; Humans; Inflammation Mediators; Lipid Metabolism; Lipoprotein Lipase; Macrophages; MicroRNAs; THP-1 Cells; Up-Regulation | 2019 |
Citrus flavonoid 5-demethylnobiletin suppresses scavenger receptor expression in THP-1 cells and alters lipid homeostasis in HepG2 liver cells.
Topics: Atherosclerosis; CD11b Antigen; Cell Differentiation; Citrus; Flavones; Foam Cells; Hep G2 Cells; Humans; Hydroxymethylglutaryl CoA Reductases; Lipid Metabolism; Macrophages; Monocytes; NF-kappa B; Protein Kinase C; Receptors, LDL; Receptors, Scavenger; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2011 |
Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.
Topics: Animals; Atherosclerosis; Butadienes; Diet; Dyslipidemias; Electrophoresis, Polyacrylamide Gel; Energy Metabolism; Enzyme Inhibitors; Flavones; Hep G2 Cells; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipoproteins, VLDL; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Mutant Strains; Nitriles; Phosphorylation; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Triglycerides | 2011 |